EUVIMEDEUVIMED entdecken
Crossref

Gold Nanoparticle‐Carrying T Cells for the Combined Immuno‐Photothermal Therapy

HyeMi Kim, Yujin Baek, Taeyong Ha, Doowon Choi, Woo Jin Lee, Yongbum Cho, Jeehun Park, Sungjee Kim, Junsang Doh iD

Small · 2023

DOI: 10.1002/smll.202301377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2023. Verfasst von HyeMi Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Scientific Instrumentation, Korea Basic Science Institute (KBSI), Daejeon, 34133, South Korea. Hauptthemen laut MEDLINE: Metal Nanoparticles, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Research Foundation of Korea, Creative-Pioneering Researchers Program through Seoul National University, Key Project of Korea Basic Science Institute Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer immunotherapy is a promising therapy to treat cancer patients with minimal toxicity, but only a small fraction of patients responded to it as a monotherapy. In this study, a strategy to boost therapeutic efficacy by combining an immunotherapy based on ex vivo expanded tumor‐reactive T cells is devised, or adoptive cell therapy (ACT), with photothermal therapy (PTT). Smart gold nanoparticles (sAuNPs), which aggregates to form gold nanoclusters in the cells, are loaded into T cells, and their photothermal effects within T cells are confirmed. When transferred into tumor‐bearing mice, large number of sAuNP‐carrying T cells successfully infiltrate into tumor tissues and exert anti‐tumor activity to suspend tumor growth, but over time tumor cells evade and regrow. Of note, ≈20% of injected doses of sAuNPs are deposited in tumor tissues, suggesting T cells are an efficient nanoparticle tumor delivery vehicle. When T cells no longer control tumor growth, PTT is performed to further eliminate tumors. In this manner, ACT and PTT are temporally coupled, and the combined immuno‐photothermal treatment demonstrated significantly greater therapeutic efficacy than the monotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal NanoparticlesNanoparticlesNeoplasmsHumansAnimalsMiceGoldT-LymphocytesCombined Modality TherapyPhototherapyCell Line, Tumor

Stichwörter der Autor:innen

T cellsadoptive cell therapygold nanoparticlesphotothermal therapy

Substanzen

Gold

Autor:innen und Institutionen

  • Center for Scientific Instrumentation, Korea Basic Science Institute (KBSI), Daejeon, 34133, South Korea.
  • Department of Materials Science and Engineering, Seoul National University, Seoul, 08826, South Korea.
  • Department of Chemistry, Pohang University of Science and Technology (POSTECH), Pohang, 37673, South Korea.
  • School of Interdisciplinary Bioscience and Bioengineering (I-Bio), Pohang University of Science and Technology (POSTECH), Pohang, 37673, South Korea.
  • SOFT Foundry Institute, Seoul National University, Seoul, 08826, South Korea.
  • Research Institute of Advanced Materials (RIAM), Institute of Engineering Research, BioMAX Institute, Seoul National University, Seoul, 08826, South Korea.

ORCID-Profile: Junsang Doh

Förderung

  • National Research Foundation of Korea
  • Creative-Pioneering Researchers Program through Seoul National University
  • Key Project of Korea Basic Science Institute Fund

Zitieren

APA

Kim, H., Baek, Y., Ha, T., Choi, D., Lee, W. J., Cho, Y., Park, J., Kim, S., & Doh, J. (2023). Gold Nanoparticle‐Carrying T Cells for the Combined Immuno‐Photothermal Therapy. Small. https://doi.org/10.1002/smll.202301377

Vancouver

Kim H, Baek Y, Ha T, Choi D, Lee WJ, Cho Y, et al. Gold Nanoparticle‐Carrying T Cells for the Combined Immuno‐Photothermal Therapy. Small. 2023. doi:10.1002/smll.202301377

BibTeX
@article{Kim2023,
  author = {Kim, HyeMi and Baek, Yujin and Ha, Taeyong and Choi, Doowon and Lee, Woo Jin and Cho, Yongbum and Park, Jeehun and Kim, Sungjee and Doh, Junsang},
  title = {Gold Nanoparticle‐Carrying T Cells for the Combined Immuno‐Photothermal Therapy},
  journal = {Small},
  year = {2023},
  doi = {10.1002/smll.202301377}
}
Kostenlos starten →